XALKORI gran 20 mg gélules à ouvrir bte 60 pce

7680694670012 CH-69467 L01ED01 07.16.1.
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
1 / 3
google

Details

Product number
6946701
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
crizotinibum 20 mg, alcohol stearylicus, poloxamerum 407, saccharum 5.71 mg, talcum, hypromellosum, macrogolum 4000, glyceroli mono/dipalmitas/stearas/oleas, triglycerida media, ad granulatum pro dosi.

Articles (1)

Xalkori 20 mg, filmüberzogenes Granulat zum Einnehmen
Granulat
60
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
5.71 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69467
Drug name
Xalkori, filmüberzogenes Granulat zum Einnehmen
Galenic form
GRFI
ATC Code
L01ED01
Authorization status
Z
Dispensation category
A
First authorization
29/08/2024
Authorization expiration date
28/08/2029
IT number
07.16.1.
Domain
Human medicine
Field of application
Onkologikum

Packaging details

Description (FR)
XALKORI gran 20 mg gélules à ouvrir bte 60 pce
Description (DE)
XALKORI Gran 20 mg Kapseln zum Öffnen Ds 60 Stk
Market launch
29/08/2024
Narcotic (BTM)
No

Other packaging sizes

XALKORI gran 50 mg gélules à ouvrir bte 60 pce
60 KAP
View
XALKORI gran 150 mg gélules à ouvrir bte 60 pce
60 KAP
View